Aveanna Beats Q3 Revenue Estimates, Posts $0.20 EPS and Raises 2026 Outlook
AVAH has more than doubled off its 52-week low of $5.93.
Summary
Aveanna reported Q3 EPS of $0.20, net income of $45.5M, revenue of $695.5M and adjusted EBITDA of $100.1M. Revenue came in above the $679.5M IBES consensus estimate, and adjusted EBITDA rose 25.0% year over year. The company also raised its full-year 2026 revenue guidance, per the 8-K filed alongside the release. That follows Q2 revenue of $670.5M, up 13.7% year over year, with the Family First acquisition closed June 1, 2026 contributing to growth. The beat plus the guidance raise is the kind of update that resets the earnings model, and it lands after a stretch of insider selling tied to the August secondary offering.
At the time of this announcement, AVAH was trading at $12.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $5.93 to $14.71. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.